Background {#Sec1}
==========

Carpal tunnel syndrome (CTS) is the most common peripheral neuropathy\[ \[[@CR1]\]. Its prevalence reported between 1 to 16% in the general adult population \[[@CR2], [@CR3]\].

CTS is characterized by numbness or tingling in the sensory distribution of the median nerve. In some cases, CTS can be accompanied by pain and/or weakness of the thenar muscles which could affect thumb abduction and opposition \[[@CR4]\].

Indicators of the disease are varied and include a combination of symptoms (e.g., paresthesia, tingling, and numbness), signs (e.g. Durkan's sign, Phalen's sign and Tinel's sign) and electrophysical studies \[[@CR1], [@CR5], [@CR6]\]. CTR is effective in most cases.

A limited number of studies have highlighted the predictors of patients' outcomes and their satisfaction following CTR \[[@CR3]--[@CR5], [@CR7]\]

Identifying preoperative predictors of clinical outcomes and post-operative satisfaction provides more information for surgical planning and preoperative consultation \[[@CR5]\]. The present study had two aims. The primary purpose of this study was to identify predictors of clinical outcomes after CTR. The secondary objective of this study was to evaluate patients' satisfaction and correlated predictors following CTR.

Methods {#Sec2}
=======

This prospective study was conducted in 2018. A sample of 152 patients with carpal tunnel syndrome who referred to the Imam Reza hospital, Kermanshah, Iran between April 2015 and April 2017, were included. Inclusion criteria were: age over 18 years, disease duration of at least 6 months and failure in medical treatment. Patients with a history of previous wrist surgery or trauma and those with diabetic neuropathy and cases with bilateral CTS were excluded. Moreover, 5 patients (3.03%) left the follow up and 8 subjects (4.84%) did not complete pre/postoperative forms \[Fig. [1](#Fig1){ref-type="fig"}\]. Fig. 1Flowchart of the study population

The present study was approved by the Scientific Research Board of the Kermanshah University of Medical Sciences. Informed written consent was obtained from all patients before enrolment.

Meticulous clinical examinations including specific provocative tests of the hand (Phalen's sign, Tinel's signs, and Durkan's tests), the Semmes--Weinstein monofilament test, and grip strength test were performed.

We performed the Semmes--Weinstein monofilament test at the most prominent finger for each patient. Results were recorded by a 5-point scale as follows: 1- normal (2.83 monofilaments), 2-diminished light touch (3.61), 3- diminished protective sensation (4.31), 4- loss of protective sensation (4.56), and 5-untestable sensation (6.65) \[[@CR8]\]. Grip strength test was conducted using a Jamar dynamometer (Sammons Preston, Bolingbrook, Illinois) \[[@CR3]\].

Electrophysiological tests were conducted pre-operatively for each patient. Sensory nerve action potential (SNAP) (in μv), the peak latency of SNAP (in ms), the peak amplitude of compound muscle action potential (in mV), and conduction velocity of the SNAP (in m/s) were recorded. According to the American Association of Electrodiagnostic Medicine criteria \[[@CR8]\] patients were categorized into three groups (mild, moderate and severe).

The Boston Carpal Tunnel Questionnaire (BCTQ) were assessed at intake and last follow -up visits to evaluate clinical outcomes.

Boston Carpal Tunnel Questionnaire (BCTQ) scores were recorded at preoperative visits and six-month post-operative visits. The BCTQ \[[@CR6]\] is a disease-specific tool that can be used to assess symptom severity, functional status, and clinical outcome of patients with CTS. BCTQ is comprised of two separate parts: a symptom severity scale (SSS) and a functional status scale (FSS). The first part comprises 11 questions (Q1 \~ Q11) concerning the severity of pain, tingling, numbness, and weakness. The functional status scale has 8 questions of activities of daily tasks. Each item scoring from 1 to 5 in the ascending order making a total score of 55 for SSS (with 11 being the best and 55 being the worst) and 40 for the FSS (with eight being the best and 40 being the worst). Mean Boston score for symptom severity and mean Boston score for functional status were obtained by dividing the total SSS by11 and total FSS by 8. BCTQ was translated into the Persian language and it was validated. All patients were managed with the minimal invasive open technique for carpal tunnel release under local anesthesia.

Age, sex, hand dominancy, smoking, symptoms duration, body mass index (BMI), the Semmes--Weinstein monofilament test, grip strength, electrophysiological severity, scores of the Boston Carpal Tunnel Questionnaire, presence of positive physical examination signs (Phalen's sign, Tinel's signs and Durkan's tests), presence of thenar atrophy and EMG abnormalities (fibrillations, positive sharp waves or fasciculations) were selected as probable predictors of clinical outcomes and patients' satisfaction.

Patients' satisfaction was determined by a 10-point verbal descriptor nominal scale (1 = very poor, 5 = fair, 10 = excellent) and recorded, at last, follow -up visits.

Statistical analysis {#Sec3}
--------------------

Data analysis was performed with SPSS 21 (SPSS Inc. Chicago, Illinois). The mean and standard deviation of quantitative variables were calculated. The normality of quantitative variables was checked by the Kolmogorov -Smirnov test. The Wilcoxon test was used to compare preoperative SSS and FSS with 6- month postoperative SSS and FSS. Because the variables of pre-operative SSS, pre-operative FSS, Satisfaction, as well as change scores in SSS and FSS were non-normal, we used nonparametric tests such as Mann-Whitney-U test, Kruskal Wallis, and Spearman correlation test for checking the relationship between mentioned variables with other variables and those that were significant entered into the linear regression model. It is notable, because dependent variables (pre-operative SSS, pre-operative FSS, Satisfaction, change score in SSS, and change score in FSS) were non-normal we take their logarithm (Ln) before doing regression tests. Significant level \< 0.05 considered as the significant level. *P* values \< 0.05 considered as the significant level.

Results {#Sec4}
=======

There were 118 (77.6%) females and 34 (22.36%) males. The mean age was 50.50 ± 7.24 years. Sixteen (10.5%) patients had CTS symptoms for less than 1 year, 123(80.9%) patients had symptoms for a period of 1 to 4 years, and 13(8.6%) of our patients were symptomatic for more than 4 years. In 69.7% of patients (106 individuals), the dominant hand was involved. \[Table [1](#Tab1){ref-type="table"}\]. Table 1personal characteristics of the subjectsVariablesFrequencyFrequency percentGenderMale3422.4Female11877.6Duration of symptomsOne year1610.51--4 year12380.9\> four years138.6Electrophysiological severityMild85.3Moderate7247.4Sever7247.4Involved sideDominant10669.7Non dominant4630.3Thenar muscle atrophyAbsent13286.8Present2013.2SmokingNo12984.9Yes2315.1HypothyroidismNo14394.1Yes95.9Phalen testPositive13588.8Negative1711.2Tinel testPositive14092.1Negative127.9Durkan testPositive14192.8Negative117.2EMG abnormalityAbsent13790.1Present159.9Monofilament testNormal85.3Diminished light touch5032.9Diminished protective sensation9260.5Loss of protective sensation21.3Loss of protective sensation21.3Previous carpal injectionYes6140.13No9159.86

Predictors of pre-operative BCTQ (SSS & FSS) {#Sec5}
--------------------------------------------

The results of univariate analyses showed that the pre- operative SSS was related to age, duration of symptoms, electrophysiological severity, and the presence of thenar muscle atrophy(*P* \< 0.05) \[Table [2](#Tab2){ref-type="table"}\]. As well as, age, duration of symptoms, and the presence of thenar muscle atrophy were related to the pre-operative FSS (*P* \< 0.05) \[Table [2](#Tab2){ref-type="table"}\]. According to the linear regression model, duration of symptoms and electrophysiological severity were the independent predictors of preoperative SSS. The model predicted 63% of the variance of pre-operative SSS \[Table [3](#Tab3){ref-type="table"}\]. Meanwhile, linear regression model showed the age, duration of symptoms, and the presence of thenar muscle atrophy as the predictors of pre-operative FSS \[Table [4](#Tab4){ref-type="table"}\]. Table 2the relationship between various variables with pre-operative SSS, pre-operative FSS, satisfaction, and change scores in SSS and FSSVariablesPre-operative SSSPre-operative FSSChange score in SSSChange score in FSSSatisfactionAge*r* = 0.210*P* = 0.009\**r* = 0.197*P* = 0.015\**r* = −0.196*P* = 0.016\**r* = 0.226*P* = 0.005\**r* = −0.193*P* = 0.017\*SexZ = 0.461*P* = 0.645Z = -0.586*P* = 0.558Z = -0.458*P* = 0.647Z = -1.243*P* = 0.214Z = -0.638*P* = 0.524BMI*r* = 0.087*P* = 0.287*r* = 0.005*P* = 0.95*r* = 0.037*P* = 0.186*r* = 0.044*P* = 0.31*r* = −0.006 *P* = 0.937Duration of symptomK2 = 8.006*P* = 0.018\*K2 = 8.007*P* = 0.018\*K2 = 8.093*P* = 0.017\*K2 = 2.638*P* = 0.267K2 = 0.725*P* = 0.696Electrophysiological SeverityK2 = 99.896*P* \< 0.001\*K2 = 1.894*P* = 0.388K2 = 99.786*P* \< 0.001\*K2 = 2.927*P* = 0.231K2 = 2.69*P* = 0.260Involved sideZ = -0.339*P* = 0.739Z = -0.437*P* = 0.662Z = -0.359*P* = 0.719Z = -0.594*P* = 0.552Z = -0.178*P* = 0.859Grip strength*r* = 0.023*P* = 0.779*r* = 0.03*P* = 0.71*r* = 0.020*P* = 0.805*r* = 0.063*P* = 0.443*r* = 0.655*P* \< 0.001\*Thenar muscle atrophyZ = -3.039*P* = 0.002\*Z = -2.392*P* = 0.017\*Z = \--3.084*P* = 0.002\*Z = -1.072*P* = 0.284Z = -1.561*P* = 0.119SmokingZ = -0.533*P* = 0.594Z = -0.240*P* = 0.810Z = -0.497*P* = 0.619Z = -0.067*P* = 0.947Z = -0.497*P* = 0.619HypothyroidismZ = -1.345*P* = 0.176Z = -0.730*P* = 0.466Z = -1.306*P* = 0.192Z = -0.145*P* = 0.885Z = -0.057*P* = 0.955Phalen testZ = -1.201*P* = 0.230Z = -1.624*P* = 0.104Z = -1.066*P* = 0.287Z = -1.766*P* = 0.077Z = -0.371*P* = 0.710Tinel testZ = -0.88*P* = 0.379Z = -0.390*P* = 0.696Z = -0.859*P* = 0.390Z = -0.531*P* = 0.595Z = -0.423*P* = 0.672Durkan testZ = -1.439*P* = 0.150Z = 1.126*P* = 0.260Z = -1.385*P* = 0.166Z = -0.790*P* = 0.430Z = -0.130*P* = 0.897EMG abnormalityZ = -0.365*P* = 0.715Z = -0.225*P* = 0.822Z = -0.381*P* = 0.704Z = -0.627*P* = 0.531Z = -0.415*P* = 0.678Monofilament testK2 = 0.445*P* = 0.931K2 = 7.56*P* = 0.056K2 = 0.604*P* = 0.896K2 = 4.705*P* = 0.195K2 = 4.780*P* = 0.189Previous carpal injectionZ = 3.71*P* = 0.151Z = 1.18*P* = 0.554Z = 3.881*P* = 0.275KZ = 7.50*P* = 0.067Z = 3.861*P* = 0.277 Table 3predicting pre-operative SSS by variables of age, duration of symptoms, electrophysiological severity, and thenar muscle atrophyPredictorsBStandard errorSig.Standard coefficient BetaCI 95%Constant2.9030.080\< 0.001--2.746--3.060Age0.0020.0010.1110.080.001--0.004Duration of symptoms0.0530.019\*0.0070.1340.015--0.019Electrophysiological severity0.2250.015\* \< 0.001**0.776**0.195--0.255Thenar muscle atrophy−0.0060.0260.822−0.012−0.059-0.046Model summary ModelRR2Adjusted R2 Age, duration of symtoms, electrophysiological severity, thenar muscle atrophy0.8040.6470.637Dependent variable: Ln SSS pre-operation Table 4predicting pre-operative FSS by variables of age, duration of symptoms, and thenar muscle atrophyPredictorsBStandard errorSig.Standard coefficient BetaCI 95%Constant0.9370.121\< 0.001--0.697--1.176Age0.0040.002\*0.0200.1850.001--0.008Duration of symptoms− 0.0630.030\*0.037−0.1650.122--0.004Thenar muscle atrophy0.0810.039\*0.0370.1650.005--0.157Model summary ModelRR2Adjusted R2 Age, duration of symtoms, thenar muscle atrophy0.3090.0950.077

Predictors of change scores in SSS and FSS {#Sec6}
------------------------------------------

Overall, the result of the present study revealed that the surgery improved outcomes \[Table [5](#Tab5){ref-type="table"}\]. Most variables did not have strong predictive power in clinical outcomes \[Table [2](#Tab2){ref-type="table"}\]. However, duration of symptoms and electrophysiological severity were predictors of the change score in SSS (*P* \< 0.05) \[Table [6](#Tab6){ref-type="table"}\]. Moreover, age was the only predictor of change scores in FSS(*P* \< 0.05) \[Table [7](#Tab7){ref-type="table"}\]. Table 5comparison of pre and post- operative SSS and FSS variables by Wilcoxon testVariablesMean rankMean + SDStatistical testSSSPre-operative76.3338.65 ± 6.22Z = -10.69*P* \< 0.001Post-operative0.001.29 ± 0.48FSSPre-operative73.503.10 ± 0.49Z = -10.80*P* \< 0.001Post-operative0.001.68 ± 0.48 Table 6predicting change score in SSS by variables of age, duration of symptoms, and electrophysiological severityPredictorsBStandard errorSig.Standard coefficient BetaCI 95%Constant2.8440.084\< 0.001--2.678--3.011Age0.0020.0010.1340.077−0.001-0.004Duration of symptoms0.0560. 20\*0.0070.1370.015--0.096Electrophysiological severity0.2310.016\* \< 0.0010.7670.199--0.263Thenar muscle atrophy−0.0030.0280.908−0.006−0.58-0.052Model summary ModelRR2Adjusted R2 Age, duration of symtoms, electrophysiological severity,Thenar muscle atrophy0.7960.6340.624 Table 7predicting change score in FSS by variable of agePredictorsBStandard errorSig.Standard coefficient BetaCI 95%Constant−0.1930.2110.362--−0.610-0.224Age0.0100.0040.0150.2010.002--0.018Model summary ModelRR2Adjusted R2 VAge0.2010.0410.034

Predictors of post-operative satisfaction {#Sec7}
-----------------------------------------

At first, we assessed the relationship between post-operative satisfaction and suggested variables. The variables of age and preoperative grip strength were correlated with the patients' satisfaction (*P* \< 0.05) \[Table [3](#Tab3){ref-type="table"}\]. In the next step, we conducted a linear regression model. Interestingly, the result of the regression model showed the preoperative grip strength as the powerful predictor of post-operative satisfaction (B = 0.026, *P* \< 0.001). However, the model did not show such a strong predictive power for age (B = − 0.003, *P* = 0.043). Overall, the model predicted 73% of the variance of post-operative satisfaction \[Table [8](#Tab8){ref-type="table"}\]. Table 8predicting satisfaction by grip strength and age by linear regression testPredictorsBStandard errorSig.Standard coefficient BetaCI 95%Constant1.3550.048\< 0.001--1.26--1.45Grip strength0.0260.002\< 0.0010.770.023--0.030Constant1.490.85\< 0.001--1.33--1.66Grip strength0.0260.002\< 0.0010.7590.023--0.030Age−0.0030.0010.043−0.0050.001Model summary ModelRR2Adjusted R2 Grip strength0.7700.5930.590 Grip strength and age0.7770.6040.599Dependent variable: Ln satisfaction

Critical complications such as tendon, muscle or nerve damages were not observed in the study.

Discussions {#Sec8}
===========

Carpal tunnel syndrome is the most common peripheral neuropathy \[[@CR9]\]. Carpal releasing surgery proved to be effective in many cases, although reported success varies. The incidence of CTS is increasing as 11% of females and 3.5% of males, with increasing life expectancy \[[@CR10]\].

Open release of the carpal tunnel, introduced by Phalen et al. (1950) is the standard treatment for the CTS \[[@CR11]\]. According to a recent review of a long-term follow-up after CTS surgery, clinical success reported between 75 and 90% \[[@CR1]\]. In spite of the considerable improvement in patients' symptoms, their satisfaction with releasing surgery is still unpredictable. In the present study, we have evaluated the predictors of clinical outcomes and satisfaction of patients with CTR.

The Boston carpal tunnel syndrome questionnaire is a disease-specific measure \[[@CR6]\]. The sensitivity of the Boston CTS Questionnaire for detecting a change after carpal tunnel surgery has been demonstrated \[[@CR6]\]. Gay et al. found that the BCTQ is more sensitive to changes in clinical stats of patients than the electrophysiological findings, clinical examination or other generic questionnaires such as the Short-Form 36 and Disabilities of the Arm, Shoulder, and Hand questionnaire \[[@CR12]\].

Some factors have been suggested as outcome predictors of carpal releasing surgery including age, gender, smoking, occupation, underlying disease, duration of symptoms, and preoperative muscle weakness or atrophy \[[@CR7], [@CR8]\] However, in this study, most variables did not have a strong predictive value on patients' outcomes. In our study, patients with severe electrophysiological findings had higher postoperative FSS score. This finding suggests that early diagnosis and treatment of carpal tunnel syndrome could improve clinical outcomes.

Moreover, our results did not demonstrate a relationship between clinical outcomes and the duration of symptoms. Eisenhardt et al. reported a recovery period of 16 days in patients whose symptoms lasted less than 1 year compared to 25 days of recovery in patients with duration of symptoms more than 1 year \[[@CR13]\]. They found that the duration of paresthesia did not have a significant effect on the outcome of CTR \[[@CR13]\].

*Grip strength* can be decreased by *CTS significantly* which can lead to losing productivity at work and daily activities \[[@CR14]\]. This study concluded that patients with a weaker preoperative grip strength had lower satisfaction following a CTR. Brown et al. reported that patients with reduced grip strength require longer postoperative duration to recover the grip strength and the recovery is also incomplete. They have suggested that this may be due to progressive median nerve damage in long-standing CTS \[[@CR11]\]. Levine et al. reported that patients' satisfaction had a moderate correlation with the improvement of the functional status score and highly with changes in the symptom severity scale score and a moderate correlation with the change of the functional status score \[[@CR6]\].

The relationship between age and patients' satisfaction after CTR is not well documented. Results of our study revealed a correlation between age and post-operative satisfaction. Hansen and Larsen \[[@CR15]\] reported that patients over 65 years old had less favorable results on the BCTQ after CTR. They concluded that age may have an adverse effect on nerve regeneration. Atroshi et al. found that age was a significant predictor of patient dissatisfaction \[[@CR16]\].

Strength and limitations {#Sec9}
------------------------

This study has shown to be powerful in three main areas: First, a large sample of patients, second, organized and detailed data on symptoms and third, a systemized physical examination.

This study had limitations. We measured patients' satisfaction only at 6 months after CTS surgery. However, studies with longer follow-up periods showed that the persistence of positive effects had no further improvement beyond 6 months \[[@CR4], [@CR17], [@CR18]\].

Furthermore, there was a substantial drop-out rate among patients between the intake and the follow-up at 6 months.

Conclusions: Results of the present study revealed that there was a significant improvement in clinical outcomes after CTS surgery. Stronger pre-operative grip strength and younger age were independent predictors of higher post-operative satisfaction. These results can be used in pre-operative counseling and management of post-operative expectations.

BCTQ

:   Boston Carpal Tunnel Questionnaire

CTR

:   Carpal Tunnel Release

CTS

:   Carpal Tunnel Syndrome

CTS

:   Symptom Severity Scale

FSS

:   Functional Status Scale
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